Membranoproliferative glomerulonephritis associated with psoriasis vulgaris

Renal Failure

Volumn 31, Issue 9, 2009, Pages 858-861

  Akoglu, Hadim ^a   Dede, Fatih ^a   Akoglu, Gulsen ^b   Gonul, Ipek Isik ^c   Odabas, Ali Riza ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Halil Sivgin Cubuk State Hospital   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

Membranoproliferative glomerulonephritis; Psoriasis; Psoriatic nephropathy

Indexed keywords

CYCLOSPORIN A; PREDNISONE;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; DISEASE ASSOCIATION; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; KIDNEY BIOPSY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PSORIASIS VULGARIS; SKIN BIOPSY; URINALYSIS;

ADOLESCENT; BIOPSY; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; KIDNEY; PSORIASIS; SKIN;

EID: 71049155815     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903180582     Document Type: Article

References (26)

1. Gudjonsson JE, Elder JT. Psoriasis: Epidemiology. Clin Dermatol. 2007;25(6):535-546.
2. Whittam LR, McGibbon DH. The management of psoriasis. Int J Clin Pract. 1998;52(7):487-491.
3. Szepietowski JC, Szepietowski T. Is renal function altered in patients with psoriasis vulgaris? J Dermatol. 2000;27(9): 569-572.
4. Cecchi R, Seghieri G, Gironi A, Tuci F, Giomi A. Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology. 1992;185(2):93-95.
5. Ahuja TS, Funtanilla M, de Groot JJ, Velasco A, Badalamenti J, Wilson S. IgA nephropathy in psoriasis. Am J Nephrol. 1998;18(5):425-429.
6. Panasiuk NN, Mukhin NA, Varshavskii VA, et al. The clinico-morphological characteristics of psoriatic nephropathy. Ter Arkh. 1990;62(6):99-103.
7. Singh NP, Prakash A, Kubba S, et al. Psoriatic nephropathy-does an entity exist? Ren Fail. 2005;27(1):123-127.
8. Kim M, Ko Y, Yeo UC, Kim Y, Oh H. Psoriasis and glomerulonephritis. Clin Exp Dermatol. 1998;23(6):295-296.
9. Yamamoto M, Yorioka T, Kawada M, et al. A case of IgA nephropathy associated with psoriasis vulgaris. Nippon Jinzo Gakkai Shi. 1994;36(6):779-783.
10. Jiao Y, Xu H, Li H, Li X. Mesangial proliferative glomerulonephritis with or without IgA deposits: The morphological characters in psoriasis vulgaris. Nephron Clin Pract. 2008; 108(3):c221-c225.
11. Sakemi T, Hayashida R, Ikeda Y, Baba N, Nishihara G, Kohda H. Membranous glomerulonephropathy associated with psoriasis vulgaris. Nephron. 1996;72(2):351-352.
12. Kaji T, Tsukada Y, Shimada A, et al. Membranous nephropathy associated with psoriasis vulgaris. Clin Nephrol. 1994; 42(1):63-64.
13. Powles AV, Cook T, Hulme B, et al. Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis. Br J Dermatol. 1993;128(2):159-165.
14. Grcevska L, Polenakovic M, Ferluga D, Vizjak A, Stavric G. Membranous nephropathy with severe tubulointerstitial and vascular changes in a patient with psoriatic arthritis treated with non-steroidal anti-inflammatory drugs. Clin Nephrol. 1993;39(5):250-253.
15. Zadrazil J, Tichi T, Horák P, et al. IgA nephropathy associated with psoriasis vulgaris: A contribution to the entity of "psoriatic nephropathy." J Nephrol. 2006;19(3):382-386.
16. Chalmers RJ, Ead RD, Whale K, Ive FA. Guttate psoriasis, glomerulonephritis and streptococcal infection. Arch Dermatol. 1983;119(12):956.
17. Alenius GM, Stegmayr BG, Dahlqvist SR. Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol. 2001;30(5):271-274.
18. Heuvels J, Maximus A, Bosmans JL, Lambert J, De Broe ME. Renal abnormalities in psoriatic patients: A review. Nephron. 1999;82(1):1-6.
19. Markham T, Watson A, Rogers S. Adverse effects with longterm cyclosporin for severe psoriasis. Clin Exp Dermatol. 2002;27(2):111-114.
20. Weinblatt ME, Coblyn JS, Fox DA, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med. 1985; 312(13):818-822.
21. Wittenberg GP, Oursler JR, Peters MS. Secondary amyloidosis complicating psoriasis. J Am Acad Dermatol. 1995;32(3): 465-468.
22. Klein M, Radhakrishnan J, Appel G. Cyclosporine treatment of glomerular diseases. Annu Rev Med. 1999;50:1-15.
23. Zelichowski G, Nowoslawski A, Wawer Z, Wa6kowicz Z. Evaluation of cyclosporin A efficacy in the treatment of steroid-resistant nephrotic syndrome in the course of membranoproliferative glomerulonephritis. Pol Arch Med Wewn. 2001;106(5):1065-1069.
24. Matsumoto H, Shibasaki T, Ohno I, et al. Effect of cyclosporin monotherapy on proteinuria in a patient with membranoproliferative glomerulonephritis. Nippon Jinzo Gakkai Shi. 1995;37(4):258-262.
25. Erbay B, Karatan O, Duman N, Ertug AE. The effect of cyclosporine in idiopathic nephrotic syndrome resistant to immunosuppressive therapy. Transplant Proc. 1988;20(3 Suppl. 4):289-292.
26. Bagheri N, Nemati E, Rahbar K, Nobakht A, Einollahi B, Taheri S. Cyclosporine in the treatment of membranoproliferative glomerulonephritis. Arch Iran Med. 2008;11(1):26-29.